Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
EchoIQ Limited ( (AU:EIQ) ) has provided an update.
Echo IQ has completed its presentation to the CPT Editorial Panel regarding its application for a Category III CPT code for EchoSolv AS in the US. While awaiting the panel’s decision, the company continues to focus on deploying EchoSolv AS in the US and progressing FDA clearance for EchoSolv HF, alongside new product development and partnership opportunities, which are advancing as planned.
The most recent analyst rating on (AU:EIQ) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
Echo IQ is an AI-driven medical technology company based in Sydney, Australia, specializing in proprietary software to enhance decision-making in cardiology.
Average Trading Volume: 1,121,678
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$161.9M
See more insights into EIQ stock on TipRanks’ Stock Analysis page.